Cite
HARVARD Citation
Nuvolone, M. et al. (2021). A safety review of drug treatments for patients with systemic immunoglobulin light chain (AL) amyloidosis. Expert opinion on drug safety. 20 (4), pp. 411-426. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nuvolone, M. et al. (2021). A safety review of drug treatments for patients with systemic immunoglobulin light chain (AL) amyloidosis. Expert opinion on drug safety. 20 (4), pp. 411-426. [Online].